Home / Resource Library / The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL

The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL

Study investigated the impact of patient fitness on outcomes in patients with CLL.